Immucell (ICCC) news

Recent news

Immucell Corporation Q2 product sales USD 7.2 million

ImmuCell Corporation (Nasdaq: ICCC) reported preliminary, unaudited product sales of $7.2 million for the second quarter of 2026, according to the company’s historical reporting patterns and sales trends. This figure aligns with the company’s seasonal performance, as demand typically shifts from…

AInvest Wire · Jul 9, 2026

Immucell announces a 12% increase in product sales in Q2 of 2026 and a 21% increase in the first six months of 2026, based on preliminary, unaudited sales results

AInvest Wire · Jul 9, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by